From what I have understood, a positive reason for expanding the trial would be to have it completed sooner. With money coming in from Germany, they could afford to add patients and they would be able to reach approval somewhat more quickly. I wouldn't see it as necessarily a negative.
News 
Market Data 
Discover 
